The occurrence of fetal microchimeric cells in endometrial tissues is a very common phenomenon in benign uterine disorders, and the lower prevalence of fetal microchimerism is associated with better uterine cancer prognoses

DNA and Cell Biology

Volumn 33, Issue 1, 2014, Pages 40-48

  Hromadnikova, Ilona ^a   Kotlabova, Katerina ^a   Pirkova, Petra ^a   Libalova, Pavla ^b   Vernerova, Zdenka ^b   Svoboda, Bohuslav ^b   Kucera, Eduard ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN BETA CHAIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; DYSLIPIDEMIA; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; FETAL MICROCHIMERISM; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; MICROCHIMERISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREGNANCY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UTERUS CANCER; UTERUS DISEASE; YOUNG ADULT;

EID: 84891696231     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2125     Document Type: Article

References (71)

1. Akhmedkhanov, A., Zeleniuch-Jacquotte, A., and Toniolo, P. (2006). Role of exogenous and endogenous hormones in endometrial cancer. Ann N Y Acad Sci 943, 296-315.
2. Alektiar, K.M., McKee, A., Lin, O., Venkatraman, E., Zelefsky, M.J., McKee, B., Hoskins, W.J., and Barakat, R.R. (2002). Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO grade 3 cancer Int J Radiat Oncol Biol Phys 54, 79-85.
3. Alvarez, T., Miller, E., Duska, L., and Oliva, E. (2012). Molecular profile of grade 3 endometrioid endometrial carcinoma: Is it a type I or type II endometrial cancer Am J Surg Pathol 36, 753-761.
4. Amant, F., Moerman, P., Neven, P., Timmerman, D., Van Limbergen, E., and Vergote, I. (2005). Endometrial cancer. Lancet 366, 491-505. (Pubitemid 41111699)
5. Artlett, C.M. (2005). Pathophysiology of fetal microchimeric cells. Clin Chim Acta 360, 1-8. (Pubitemid 41225389)
6. Bakkum-Gamez, J.N., Gonzalez-Bosquet, J., Laack, N.N., Mariani, A., and Dowdy, S.C. (2008). Current issues in the management of endometrial cancer. Mayo Clin Proc 83, 97-112.
7. Banno, K., Kisu, I., Yanokura, M., Masuda, K., Kobayashi, Y., Ueki, A., Tsuji, K., Yamagami, W., Nomura, H., Susumu, N., and Aoki, D. (2012). Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics. Biochem Res Int 2012, 738274.
8. Bayes-Genis, A., Bellosillo, B., de la Calle, O., Salido, M., Roura, S., Ristol, F.S., Soler, C., Martinez, M., Espinet, B., Serrano, S., Bayes de Luna, A., and Cinca, J. (2005). Identification of male cardiomyocytes of extracardiac origin in the hearts of women with male progeny: male fetal cell microchimerism of the heart. J Heart Lung Transplant 24, 2179-2183. (Pubitemid 41814743)
9. Bianchi, D.W., Zickwolf, G.K., Weil, G.J., Sylvester, S., and De-Maria, M.A. (1996). Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 93, 705-708. (Pubitemid 26041153)
10. Bloch, E.M., Jackman, R.P., Lee, T.H., and Busch, M.P. (2013). Transfusion-associated microchimerism: the hybrid within. Transfus Med Rev 1, 10-20.
11. Buemi, M., Allegra, A., D'Anna, R., Coppolino, G., Crasc̀ E, Giordano, D., Loddo, S., Cucinotta, M., Musolino, C., and Teti, D. (2007). Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension. Am J Obstet Gynecol 196, 68.e1-e6.
12. Campagnoli, C., Fisk, N., Overton, T., Bennett, P., Watts, T., and Roberts, I. (2000). Circulating hematopoietic progenitor cells in first trimester fetal blood. Blood 95, 1967-1972. (Pubitemid 30151633)
13. Campagnoli, C., Roberts, I.A., Kumar, S., Bennett, P.R., Bellantuono, I., and Fisk, N.M. (2001). Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98, 2396-2402.
14. Cha, D., Khosrotehrani, K., Kim, Y., Stroh, H., Bianchi, D.W., and Johnson, K.L. (2003). Cervical cancer and microchimeris. Obstet Gynecol 102, 774-781.
15. Chan, T.F., Wu, C.H., Changchien, C.C., and Yang, C.Y. (2011). Mortality from breast, endometrial and ovarian cancers among grand multiparous women in Taiwan. Aust N Z J Obstet Gynaecol 51, 548-552.
16. Chen, Y.L., Wang, K.L., Chen, M.Y., Yu, M.H., Wu, C.H., Ke, Y.M., Chen, Y.J., Chang, Y.Y., Hsu, K.F., and Yen, M.S. (2013). Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: a retrospective observational study of Taiwanese Gynecologic Oncology Group. J Gynecol Oncol 24, 14-20.
17. Clayton, E.M., Jr., Feldhaus, W.D., and Whitacre, F.E. (1964). Fetal erythrocytes in the maternal circulation of pregnant women. Obstet Gynecol 23, 915-919.
18. Cramer, D.W. (2012). The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin North Am 26, 1-12.
19. de Bellefon, L.M., Heiman, P., Kanaan, S.B., Azzouz, D.F., Rak, J.M., Martin, M., Roudier, J., Roufosse, F., and Lambert, N.C. (2010). Cells from a vanished twin as a source of microchimerism 40 years later. Chimerism 2, 56-60.
20. Dhimolea, E., Denes, V., Lakk, M., Al-Bazzaz, S., Aziz-Zaman, S., Pilichowska, M., and Geck, P. (2013). High male chimerism in the female breast shows quantitative links with cancer. Int J Cancer 133, 835-842.
21. Dubernard, G., Aractingi, S., Oster, M., Rouzier, R., Mathieu, M.C., Uzan, S., and Khosrotehrani, K. (2008). Breast cancer stroma frequently recruits fetal derived cells during pregnancy. Breast Cancer Res 10:R14.
22. Edlinger, M., Concin, N., Concin, H., Nagel, G., Ulmer, H., and Gö bel, G. (2013). Lifestyle-related biomarkers and endometrial cancer survival: elevated gemma-glutamyltransferase as an important risk factor. Cancer Epidemiol 37, 156-161.
23. Fleta Asin, B., Gonzalvo Liarte, M.C., and Cia Gomez, P. (2006). Chimerism: origin and medical implications. Rev Clin Esp 206, 340-342. (Pubitemid 44193061)
24. Friberg, E., Orsini, N., Mantzoros, C.S., and Wolk, A. (2007). Diabetes mellitus and risk of endometrial cancer: a metaanalysis. Diabetologia 50, 1365-1374. (Pubitemid 46879010)
25. Gadi, V.K., and Nelson, J.L. (2007). Fetal microchimerism in women with breast cancer. Cancer Res 67, 9035-9038. (Pubitemid 47535887)
26. Gadi, V.K., Malone, K.E., Guthrie, K.A., Porter, P.L., and Nelson, J.L. (2008). Case-control study of fetal microchimerism and breast cancer. PLoS One 3, e1706.
27. Gadi, V.K. (2009). Fetal microchimerism and cancer. Cancer Lett 276, 8-13.
28. Gadi, V.K. (2010). Fetal microchimerism in breast from women with and without breast cancer. Breast Cancer Res Treat 121, 241-244.
29. Gilmore, G.L., Haq, B., Shadduck, R.K., Jasthy, S.L., and Lister, J. (2008). Fetal-maternal microchimerism in normal parous females and parous female cancer patients. Exp Hematol 36, 1073-1077.
30. Grossman, E., Messerli, F.H., Boyko, V., and Goldbourt, U. (2002). Is there an association between hypertension and cancer mortality Am J Med 112, 479-486. (Pubitemid 34450709)
31. Guetta, E., Gordon, D., Simchen, M.J., Goldman, B., and Barkai, G. (2003). Hematopoietic progenitor cells as targets for noninvasive prenatal diagnosis: detection of fetal CD34 + cells and assessment of post-delivery persistence in the maternal circulation. Blood Cells Mol Dis 30, 13-21. (Pubitemid 36378864)
32. Hromadnikova, I., Benesova, M., Zejskova, L., Stehnova, J., Doucha, J., Sedlacek, P., Dlouha, K., and Krofta, L. (2009). The effect of DYS-14 copy number variations on extracellular fetal DNA quantification in maternal circulation. DNA Cell Biol 28, 351-358.
33. Hromadnikova, I., Zlacka, D., Hien Nguyen, T.T., Sedlackova, L., Zejskova, L., and Sosna, A. (2008). Fetal cells of mesenchymal origin in cultures derived from synovial tissue and skin of patients with rheumatoid arthritis. Joint Bone Spine 75, 563-566.
34. Kaaks, R., Lukanova, A., and Kurzer, M.S. (2002). Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11, 1531-1543. (Pubitemid 36020003)
35. Kamper-Jørgensen, M., Biggar, R.J., Tjønneland, A., Hjalgrim, H., Kroman, N., Rostgaard, K., Stamper, C.L., Olsen, A., Andersen A-MN, and Gadi, V.K. (2012). Opposite effects of microchimerism on breast and colon cancer. Eur J Cancer 48, 2227-2235.
36. Khan, K.N., Kitajima, M., Hiraki, K., Fujishita, A., Sekine, I., Ishimaru, T., and Masuzaki, H. (2010). Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum Reprod 25, 642-653.
37. Khosrotehrani, K., and Bianchi, D.W. (2005). Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci 118, 1559-1563. (Pubitemid 40691884)
38. Kurman, R.J., Ellenson, L.H., and Ronnett, B.M. (2011). Blaustein's Pathology of the Female Genital Tract, 6th ed. (Springer, New York), pp. 460-476.
39. Lapaire, O., Hosli, I., Zanetti-Daellenbach, R., Huang, D., Jaeggi, C., Gatfield-Mergenthaler, S., Hahn, S., and Holzgreve, W. (2007). Impact of fetal-maternal microchimerism on women's health-a review. J Matern Fetal Neonatal Med 20, 1-5. (Pubitemid 47224623)
40. Lapierre, V., Aupérin, A., Robinet, E., Ferrand, C., Oubouzar, N., Tramalloni, D., Saas, P., Debaene, B., Lasser, P., and Tiberghien, P. (2007). Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion 47, 1691-1699. (Pubitemid 47300616)
41. Lee, E.S.M., Bou-Gharios, G., Seppanen, E., Khosrotehrani, K., and Fisk, N.M. (2010). Fetal stem cell microchimerism: naturalborn healers or killers Mol Hum Reprod 16, 869-878.
42. Lucenteforte, E., Bosetti, C., Talamini, R., Montella, M., Zucchetto, A., Pelucchi, C., Franceschi, S., Negri, E., Levi, F., and La Vecchia, C. (2007). Diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension. Br J Cancer 97, 995-998. (Pubitemid 47519295)
43. Luppi, P., Powers, R.W., Verma, V., Edmunds, L., Plymire, D., and Hubel, C.A. (2010). Maternal circulating CD34 + VEGFR-2 + and CD133 + VEGFR-2 + progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia. Reprod Sci 17, 643-652.
44. Milne, F.H., Judge, D.S., Preen, D.B., and Weinstein, P. (2011). Early life environment, life history and risk of endometrial cancer. Med Hypotheses 77, 626-632.
45. Miura, S., Khan, K.N., Kitajima, M., Hiraki, M., Moriyama, S., Masuzaki, H., Samejima, T., Fujishita, A., and Ishimaru, T. (2006). Differential infiltration of macrophages and prostaglandin production by different uterine leiomyomas. Hum Reprod 21, 2545-2554. (Pubitemid 44542145)
46. Mueller, U.W., Hawes, C.S., Wright, A.E., Petropoulos, A., De-Boni, E., Firgaira, F.A., Morley, A.A., Turner, D.R., and Jones, W.R. (1990). Isolation of fetal trophoblast cells from peripheral blood of pregnant women. Lancet 336, 197-200. (Pubitemid 20229057)
47. Nassar, D., Droitcourt, C., Mathieu-d'Argent, E., Kim, M.J., Khosrotehrani, K., and Aractingi, S. (2012). Fetal progenitor cells naturally transferred through pregnancy participate in inflammation and angiogenesis during wound healing. FASEB J 26, 149-157.
48. Nguyen Huu, S., Dubernard, G., Aractingi, S., and Khosrotehrani, K. (2006). Feto-maternal cell trafficking: a transfer of pregnancy associated progenitor cells. Stem Cell Rev 2, 111-116. (Pubitemid 46132378)
49. Nguyen Huu, S., Oster, M., Avril, M.F., Boitier, F., Mortier, L., Richard, M.A., Kerob, D., Maubec, E., Souteyrand, P., Moguelet, P., Khosrotehrani, K., and Aractingi, S. (2009). Fetal microchimeric cells participate in tumour angiogenesis in melanomas occurring during pregnancy. Am J Pathol 174, 630-637.
50. O'Donoghue, K., and Chan, J. (2006). Human fetal mesenchymal stem cells. Curr Stem Cell Res Ther 1, 371-386.
51. O'Donoghue, K., Choolani, M., Chan, J., de la Fuente, J., Kumar, S., Campagnoli, C., Bennett, P.R., Roberts, I.A., and Fisk, N.M. (2003). Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis. Mol Hum Reprod 9, 497-502. (Pubitemid 36874308)
52. Olson, S.H., Chen, C., De Vivo, I., Doherty, J.A., Hartmuller, V., Horn-Ross, P.L., Lacey, J.V., Lynch, S.M., Sansbury, L., and Setiawan, V.W. (2009). Maximizing resources to study an uncommon cancer: E2C2-Epidemiology of Endometrial Cancer Consortium. Cancer Causes Control 20:491-496.
53. Pallarés, J., Velasco, A., Eritja, N., Santacana, M., Dolcet, X., Cuatrecasas, M., Palomar-Asenjo, V., Catasú s, L., Prat, J., and Matias-Guiu, X. (2008). Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma. Mod Pathol 21, 691-699. (Pubitemid 351744834)
54. Parant, O., Dubernard, G., Challier, J.C., Oster, M., Uzan, S., Aractingi, S., and Khosrotehrani, K. (2009). CD34 + cells in maternal placental blood are mainly fetal in origin and express endothelial markers. Lab Invest 89, 915-923.
55. Purdie, D.M., and Green, A.C. (2001). Epidemiology of endometrial cancer. Best Practise Res Clin Obstet Gynaecol 15, 341-354. (Pubitemid 32631468)
56. Rapp, K., Schroeder, J., Klenk, J., Stoehr, S., Ulmer, H., Concin, H., Diem, G., Oberaigner, W., and Weiland, S.K. (2005). Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 93, 1062-1067. (Pubitemid 41548403)
57. Savvidou, M.D., Xiao, Q., Kaihura, C., Anderson, J.M., and Nicolaides, K.H. (2008). Maternal circulating endothelial progenitor cells in normal singleton and twin pregnancy. Am J Obstet Gynecol 198, 414.e1-e5.
58. Sawaya, H.H.B., Jimenez, S.A., and Artlett, C.M. (2004). Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis. Rheumatology 43, 965-968. (Pubitemid 39144441)
59. Schmandt, R.E., Iglesias, D.A., Co, N.N., and Lu, K.H. (2011). Understanding obesity and endometrial cancer risk: opportunities for preventation. Am J Obstet Gynecol 205, 518-525.
60. Schottenfeld, D.J. (1995). Epidemiology of endometrial neoplasia. Cell Biochem Suppl 23, 151-159.
61. Seth, D., Garmo, H., Wigertz, A., Holmberg, L., Hammar, N., Jungner, I., Lambe, M., Walldius, G., and van Hemelrijck, M. (2012). Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study. Int J Mol Epidemiol Genet 3, 122-133.
62. Sherman, M.E. (2000). Theories of endometrial carcinogenesis: a multidisciplinary approach. Med Pathol 13, 295-308. (Pubitemid 30207514)
63. Soslow, R.A., Bissonnette, J.P., Wilton, A., Ferguson, S.E., Alektiar, K.M., Duska, L.R., and Oliva, E. (2007). Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences. Am J Surg Pathol 31, 979-987. (Pubitemid 47012293)
64. Trentham-Dietz, A., Nichols, H., Hampton, J.M., and Newcomb, P. (2006). Weight change and risk of endometrial cancer. Int J Epidemiol 35, 151-158. (Pubitemid 43205462)
65. van der Weyden, L., and Adams, D.J. (2007). The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta 1776, 58-85. (Pubitemid 47332074)
66. Vervoordeldonk, S.F., Doumaid, K., Remmerswaal, E.B., ten Berge, I.J., Wilmink, J.M., de Waal, L.P., and Boog, C.J. (1998). Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion. Br J Haematol 4, 1004-1009. (Pubitemid 28410532)
67. von Gruenigen, V.E., Waggoner, S.E., Frasure, H.E., Kavanagh, M.B., Janata, J.W., Rose, P.G., Courneya, K.S., and Lerner, E. (2011). Lifestyle challenges in endometrial cancer survivorship. Obstet Gynecol 117, 93-100.
68. Walknowska, J., Conte, F.A., and Grumbach, M.M. (1969). Practical and theoretical implications of fetal-maternal lymphocyte transfer. Lancet 1, 1119-1122.
69. Wernli, K.J., Ray, R.M., Gao, D.L., De Roos, A.J., Checkoway, H., and Thomas, D.B. (2006). Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women. Cancer Causes Control 17, 949-955. (Pubitemid 44078286)
70. Yan, Z., Lambert, N.C., Guthrie, K.A., Porter, A.J., Loubiere, L.S., Madeleine, M.M., Stevens, A.M., Hermes, H.M., and Nelson, J.L. (2005). Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med 118, 899-906. (Pubitemid 41097469)
71. Zagouri, F., Dimopoulos, A.M., Fotiou, S., Kouloulias, V., and Papadimitriou, C.A. (2009). Treatment of early uterine sarcomas: disentangling adjuvant modalities. World J Surg Oncol 7, 38.